Sathyaraj Asaithambi
Also known as: Sathyaraj A, Aasaithambi S, S Aasaithambi, S. Aasaithambi
Novartis Healthcare Private Limited, Indegene Lifesystems Pvt Ltd, University of Madras, Point Perfect Transcription Services Pvt. Ltd.
About
I'm a data scientist and AI specialist with over 20 years of experience turning complex data into actionable insights for executives. My foundation in molecular biology grounds the way I think about pharma problems; my work in advanced analytics, NLP, and generative AI is how I solve them.
At Novartis, I lead data science for workforce and organizational intelligence architecting LLM-based solutions, RAG pipelines, and multi-agent AI systems that turn fragmented HR, skills, and engagement signals into predictive, explainable insight. Recent work includes:
Predictive algorithms, variance correction, and scenario simulation
Building prototypes that combine graph embeddings, task-level decomposition, and LLM summarization to score key variable outcomes
Designing PoCs that fuse data, learning signals, and semantic clustering for long-term strategy
Establishing KPI frameworks and data ecosystems for enterprise rollout across key initiatives
What I've built before this
I've spent most of my career pioneering new analytics capabilities inside pharma repeatedly taking ideas from PoC to enterprise-grade service:
Social Media Intelligence CoE — built from PoC into the preferred listening partner for Global & US commercial BUs, with multilingual NLP for EU and Asian markets, powering patient-journey mapping, influencer analytics, message testing, and clinical endpoint assessment
Communications & Engagement Analytics — campaign measurement, internal/external engagement, SEO analytics for corporate affairs
Commercial & Brand Strategy — situational analysis, KOL mapping, market sizing, and marketing-mix modeling for pre-launch brands
Clinical Trial Analytics — led a 10-person team delivering insight products at 95% quality, onboarding two major pharma clients
How I think about the work
The hard part of AI in pharma isn't the model; it's connecting the model to a business question an executive will stake a decision on. I spend as much time on use-case prioritization, stakeholder alignment, and value realization as I do on architectures. I care about explainability, fairness-aware ML, and governance as much as I care about accuracy.
My passion lies in applying Generative AI, synthetic data, and real-world evidence to unlock new possibilities in patient engagement and strategic workforce planning. I’ve been recognized globally by Social Intelligence Lab, ESOMAR, and GreenBook, and have shared my perspectives at multiple forums.
Employment
-
Novartis Healthcare Private Limited Director, Data Science2015 - Present
-
Indegene Lifesystems Pvt Ltd Associate Manager2012 - 2015
-
Point Perfect Transcription Services Pvt. Ltd. Head of Training and Quality2006 - 2012
Education
-
University of Madras Msc. Molecular Biology2004 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Decision Support or High-Risk? Classifying AI Workforce-Intelligence Systems Under the EU AI Act Save
- <p>Can You Trust the Graph Beneath the Agent? A Reliability Metrology for Enterprise Skills Graphs: The FACTS Dimensions and the Skills Graph Reliability Index</p> Save
- Decision Support or High-risk? Classifying AI Workforce-intelligence Systems under the EU AI Act Save
- Can You Trust the Graph Beneath the Agent? A Reliability Metrology for Enterprise Skills Graphs: The FACTS Dimensions and the Skills Graph Reliability Index Save
- Understanding stakeholders’ experience with sickle cell disease by social media listening across Europe Save
- Patient Experiences and Insights on Chronic Ocular Pain: Social Media Listening Study Save
- Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study Save
- Patient Experiences and Insights on Chronic Ocular Pain: Social Media Listening Study (Preprint) Save
- Understanding the Lived Experiences of Patients With Melanoma: Real-World Evidence Generated Through a European Social Media Listening Analysis Save
- POSB352 Mining Socialmedia to Understand Unmet Need and Treatment Experience in Patients with Atypical Hemolytic Uremic Syndrome (AHUS) Save